Glycycoumarin prevents hepatic steatosis through activation of adenosine 5,-monophosphate (AMP)-activated protein kinase signaling pathway and up-regulation of BTG1/Tob-1
2017 ◽
Vol 34
◽
pp. 277-286
◽
2017 ◽
Vol 15
(11)
◽
pp. 847-854
◽
2011 ◽
Vol 342
(2)
◽
pp. 153-159
◽
2013 ◽
Vol 41
(1)
◽
pp. 349-350
◽